I HIGHLY recommended it several times several months ago. If you did, you've doubled your money. Or if you're like me, trading calls, you've more than doubled your money.
Affymax is a great example of a viable biotech with an effective product, major partner, and great sales potential....along with a realistic chance of being bought out.
Dendreon is the EXACT OPPOSITE. I can't wait to initiate another PUT position before earnings. Nothing is a sure thing...but DNDN going lower is about as sure as you can be:-)
Sentiment: Strong Sell
Sorry, this post was meant for the DNDN board
Sentiment: Strong Buy